Epidemiology of atherogenic dyslipidemia in an urban area of the city of Barcelona;Epidemiología de la dislipidemia aterogénica en un área urbana de la ciudad de Barcelona

Clinica e Investigacion en Arteriosclerosis

Volumn 26, Issue 1, 2014, Pages 17-19

  Caballero Sarmiento, Rafael ^a  

^a Laboratorio del Centro de Asistencia Primaria (CAP) Manso de Barcelona   (Spain)

Author keywords

Atherogenic dyslipidemia; Epidemiology; HDL cholesterol; Triglycerides

Indexed keywords

GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGED; ANALYSIS; ATHEROSCLEROSIS; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; PREVALENCE; SPAIN; URBAN POPULATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD GLUCOSE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; SPAIN; URBAN POPULATION;

EID: 84893866772     PISSN: 02149168     EISSN: 15781879     Source Type: Journal    
DOI: 10.1016/j.arteri.2013.11.005     Document Type: Article

References (8)

1. Consenso multidisciplinar sobre dislipemia aterogénica. Clin Invest Arterioscl 2013, 25:83-91.
2. Standards of medical care in diabetes-2008. Diabetes Care 2008, 31(Suppl 1):S12-S54. American Diabetes Association.
3. Perk J., de Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J 2012, 33:1635-1701.
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3413-3421.
5. Grundy, Scott M., Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. JACC 2004, 3:20-32.
6. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012:55;88-93.
7. Grau M., Elosua R., Cabrera de León A., Guembe M.J., Baena-Diez J.M., Vega Alonso T., et al. Factores de riesgo cardiovascular en España en la primera década del sigloxxi: análisis agrupados con datos individuales de 11 estudios de base poblacional, estudio DARIOS. Rev Esp Cardiol 2011, 64:295-304.
8. González-Juanatey J.R., Millán J., Alegría E., Guijarro C., Lozano J.V., Vitale G.C. Prevalencia y característica de la dislipemia en pacientes en prevención primaria y secundaria tratados con estatinas en España. Estudio DYSIS-España. Rev Esp Cardiol 2011, 64:286-294.